Tomohiro Hori Selected Research

Tomohiro Hori Research Topics

Disease

3	Neoplasms (Cancer) 12/2023 - 01/2017
3	Succinyl-CoA:3-oxoacid CoA transferase deficiency 01/2015 - 03/2013
2	Hypothyroidism 09/2017 - 12/2012
2	Kaposiform Hemangioendothelioma 11/2016 - 08/2013
2	Ketosis 01/2015 - 09/2013
1	Jaundice (Icterus) 12/2023
1	Chronic Thyroiditis 12/2023
1	Autoimmune Hepatitis 12/2023
1	Hydronephrosis 03/2023
1	Ureteral Obstruction 03/2023
1	Non-Muscle Invasive Bladder Neoplasms 11/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Thrombotic Microangiopathies 11/2018
1	Neuroblastoma 11/2018
1	Hemangioendothelioma 01/2017
1	Hemangioma (Angioma) 11/2016
1	Kasabach-Merritt Syndrome 11/2016
1	Hypoproteinemia 03/2016
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 03/2016
1	Tetany (Spasmophilia) 03/2016
1	Edema (Dropsy) 03/2016
1	Diarrhea 03/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 03/2016
1	Hypoalbuminemia 03/2016
1	Hypoglycemia (Reactive Hypoglycemia) 07/2014
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2012
1	Hepatitis 12/2012
1	Mycoses (Diseases, Fungus) 12/2012
1	Reye Syndrome (Reye's Syndrome) 07/2010

Drug/Important Bio-Agent (IBA)

3	Everolimus FDA Link 01/2017 - 03/2016
3	Beta ketothiolase deficiencyIBA 01/2015 - 09/2013
3	TransferasesIBA 01/2015 - 03/2013
3	Coenzyme A (CoA)IBA 01/2015 - 03/2013
2	veltuzumabIBA 12/2023 - 01/2020
2	AntibodiesIBA 09/2017 - 12/2012
2	Propranolol (Inderal)FDA LinkGeneric 11/2016 - 03/2016
2	succinyl-coenzyme A (succinyl-CoA)IBA 01/2015 - 03/2013
2	Acetyl-CoA C-Acyltransferase (beta Ketothiolase)IBA 01/2015 - 07/2014
1	Alanine Transaminase (SGPT)IBA 12/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023
1	BilirubinIBA 12/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2023
1	Prednisolone (Predate)FDA LinkGeneric 12/2023
1	Transcription Factor 4IBA 12/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2023
1	GlypicansIBA 12/2023
1	Aminolevulinic Acid (Levulan)FDA Link 11/2022
1	Complement Factor H (Factor H)IBA 11/2018
1	AutoantibodiesIBA 11/2018
1	Complement System Proteins (Complement)IBA 11/2018
1	eculizumab FDA Link 11/2018
1	anti-thyroglobulinIBA 09/2017
1	Iodide Peroxidase (Deiodinase)IBA 09/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016
1	Serum AlbuminIBA 03/2016
1	ElectrolytesIBA 03/2016
1	Immunoglobulin G (IgG)IBA 03/2016
1	Acetyl-CoA C-Acetyltransferase (Acetyl Coenzyme A Acetyltransferase)IBA 01/2015
1	acylcarnitineIBA 01/2015
1	AcidsIBA 01/2015
1	KetonesIBA 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2013
1	RNA Splice SitesIBA 03/2013
1	Interleukin-18 (Interleukin 18)IBA 12/2012
1	Carnitine palmitoyl transferase 2 deficiencyIBA 07/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2010

Therapy/Procedure

3	Therapeutics 11/2018 - 03/2016
1	Stents 03/2023
1	Nephrotomy 03/2023
1	Intravesical Administration 11/2022
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2018
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2016
1	Drug Therapy (Chemotherapy) 08/2013